Journal of Pharmaceutical Policy and Practice

Titel Veröffentlichungsdatum Sprache Zitate
Counting the cost of public and philanthropic R&D funding: the case of olaparib2022/08/16English
Impact of university students’ awareness and attitudes on vaccination practices for human papillomavirus, and perception on self-sampling for cervical cancer screening2022/10/29English
An investigation into the pharmaceutical advertising in Iranian medical journals2022/03/07English
Why we should have more collaboration on HTA in Europe: the example of sofosbuvir2015/10/05English
The effective and innovative cost saving of software in managing unregistered drugs2015/10/05English
30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?2015/10/05English
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences2015/10/05English
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines2015/10/05English
Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure2015/10/05English
A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results2015/10/05English
Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines2015/10/05English
Scottish collaboration to integrate medicine therapy between out-patient and in-patient sectors2015/10/05English
A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?2015/10/05English
Impact of delisting OTC medicines from reimbursement list2015/10/05English
Policy cooperation and interface issues2015/10/05English
Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities2015/10/05English
Affordable innovation: future directions in pharmaceutical policy2015/10/05English
Financial based agreements and performance based agreements: the Belgian experience2015/10/05English
Determining the prices of the medicines in the absence of superiority over alternative medical technology2015/10/05English
The prices outpatients have to pay for purchasing medicines in Armenia2015/10/05English
Retrospective financial analysis of medicines reimbursement services in community pharmacy2015/10/05English
Pharmaceutical pricing and reimbursement policies: perspectives for the future2015/10/05English
Pharmaceutical distribution remuneration in Europe2015/10/05English
Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer2015/10/05English
Policy options to deal with high-cost medicines – survey with European policy-makers2015/10/05English
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment2015/10/05English
Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs2015/10/05English
Policies beyond the crisis: lesson learned2015/10/05English
Reimbursement measures in European countries – findings of a bibliometric literature review2015/10/05English
The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system2015/10/05English